跳至主要内容
临床试验/DRKS00033540
DRKS00033540招募中不适用

PRAESIIDIUM – A data collection longitudinal cohort for a machine learning model training

Medizinische Universität Graz0 个研究点目标入组 75 人开始时间: 2024年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • ?Family history of type 2 diabetes (First or second degree relatives)
  • ?Normal weight individuals (BMI 18.5-24.9)
  • ?Signed informed consent for participation
  • ?Ownership of a smartphone running Android or iOS

排除标准

  • ?Non-compliance
  • ?Ongoing treatment with immunosuppressive and/or anti-inflammatory medications (NSAIDs, glucocorticoids, chemotherapy, biologicals.)
  • ?Ongoing treatment with glucose lowering drugs, except if anti-diabetic medication has not been stopped - for metformin one month, for GLP-1 RA, tirzepatide - two months prior enrolment
  • ?Presence of autoimmune and/or inflammatory disease.
  • ?Skin conditions hindering application of continuous glucose monitoring systems
  • ?Diabetes or prediabetes as diagnosed by ADA/WHO criteria according to fasting glucose and HbA1c
  • ?Factors otherwise limiting the participation in the study according to the judgement of the investigator
  • ?Pregnancy or intention to get pregnant during the study timeline.

研究者

相似试验